Taliglucerase alfa
Taliglucerase alfa is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand name including ELELYSO. Available dosage forms: injection, powder, for solution, injection, powder, lyophilized, for solution, liquid.
Drug details
- Generic Name
- Taliglucerase alfa
- Brand Names
- ELELYSO
- Application Number
- BLA022458
- Sponsor
- Protalix Ltd
- NDC Codes
- 6
- Dosage Forms
- INJECTION, POWDER, FOR SOLUTION, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, LIQUID
- Routes
- INTRAVENOUS
- Active Ingredients
- TALIGLUCERASE ALFA
Indications and Usage
1 INDICATIONS AND USAGE ELELYSO is indicated for the treatment of patients 4 years of age and older with a confirmed diagnosis of Type 1 Gaucher disease. ELELYSO is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for the treatment of patients 4 years and older with a confirmed diagnosis of Type 1 Gaucher disease ( 1 ).